ArticleSexual medicine2026
Efficacy, reliability, and patient satisfaction with Rigicon Infla10 X and Infla10 AX inflatable penile prostheses: a retrospective single-center analysis.
Article in Sexual medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inflatable penile prosthesis implantation is a well-established treatment option for men with erectile dysfunction refractory to conservative therapies. However, patient-reported outcome data for the Rigicon Infla10 prosthesis remain limited. This study aimed to evaluate 12-month patient-reported outcomes following primary implantation of Rigicon Infla10 X and Infla10 AX devices and to explore potential differences according to implant model and pump type. Methods: This retrospective single-center, single-surgeon cohort study included 275 patients who underwent primary Rigicon Infla10 X or Infla10 AX implantation between 2021 and 2024 and completed 12-month follow-up. Erectile function was assessed using the International Index of Erectile Function-Erectile Function domain (IIEF-EF), while postoperative satisfaction was evaluated using the Quality of Life and Sexuality with Penile Prosthesis (QoLSPP) questionnaire. Ease of inflation and deflation was assessed using a 10-point numeric rating scale. Subgroup analyses were performed according to implant model and pump type. Results: Mean preoperative IIEF-EF score increased from 6.09 ± 1.47 to 24.07 ± 1.78 at 12 months. The overall mean QoLSPP total score was 4.19 ± 0.16. QoLSPP scores did not differ significantly between the Infla10 X and Infla10 AX groups (4.20 ± 0.18 vs. 4.18 ± 0.16; Discussion: Primary Rigicon Infla10 implantation was associated with substantial improvement in erectile function and favorable patient-reported outcomes at 12 months. Although the Pulse pump was associated with improved ease-of-use ratings, these differences did not translate into higher overall satisfaction scores. Interpretation of pump-related comparisons should be cautious because pump type was era-dependent and not randomly assigned. Prospective studies with longer follow-up are warranted to confirm these findings and further evaluate device-related outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.